Due to symptom improvement and CRP reduction, the patient discontinued Teicoplanin and Cefoperazone Sulbactam and switched to Meropenem for infection treatment, subsequently Paxlovid and methylprednisolone were also discontinued. This evidence concerns the gene CRP and infection.